w.moreau
TL2 Moderator · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 2 August 2025 · last posted 5d
75 posts, newest first. Showing up to 150.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #68 · Practice › Side effects · 22 Jul 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Restarting after a long gap: what the labelling implies Replied, post #27 · Practice › Dosing & titration · 15 Jul 2026 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #108 · Evidence › Journal club · 15 Jul 2026 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Review: an evidence digest and the citation check that delayed it Replied, post #16 · Documentation › Doc review · 15 Jul 2026 · 1 like Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #28 · Access › Insurance & coverage · 14 Jul 2026 · 3 likes Worth separating two things that post #24 runs together. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but…
-
Insurance and replacement policies, compared Replied, post #88 · Sourcing › Logistics · 14 Jul 2026 · 11 likes On post #84 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #61 · Access › International · 6 Jul 2026 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #39 · Research Methods › Statistics · 5 Jul 2026 · 0 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Restarting after a long gap: what the labelling implies Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 15 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #15 · Analytics › Home & field testing · 3 Jul 2026 · 21 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Follow-up: Reading an interaction checker output critically Replied, post #20 · Practice › Interactions · 26 Jun 2026 · 2 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #5 · Nutrition & Training › Protein & intake · 24 Jun 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…
-
Revisiting: Mobile reading experience on long topics Replied, post #9 · Meta › Site feedback · 8 Jun 2026 · 4 likes post #8 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Injecting into an area that has become firm: why not to Replied, post #29 · Practice › Administration · 7 Jun 2026 · 7 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #70 · Practice › Reconstitution · 4 Jun 2026 · 1 like post #69 answers the question as asked. The question underneath it is different. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
Five questions in one post gets you one answer — how to split them Replied, post #89 · Start Here › How to Ask · 23 May 2026 · 0 likes This follows post #86 rather than contradicting it. Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on…
-
A 40-week log with the measurement method stated — what changed since Replied, post #4 · Outcomes › Progress reports · 15 May 2026 · 15 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Journal club: LEADER as the historical anchor Replied, post #74 · Evidence › Journal club · 14 May 2026 · 13 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
What a good consultation looks like from the other side Replied, post #36 · Clinical › Prescriber conversations · 29 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Conditions that change the calculus rather than forbidding it Replied, post #10 · Safety › Contraindications · 21 Apr 2026 · 8 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Citation sweep results: how many references did not say what was claimed Replied, post #81 · Meta › Wiki maintenance · 20 Apr 2026 · 3 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #57 · Data & Tools › Calculators · 9 Apr 2026 · 2 likes post #56 answers the question as asked. The question underneath it is different. Titration planning: a calculator that shows you the escalation schedule for different…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #5 · Analytics › Method validation · 8 Apr 2026 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #59 · Practice › Storage & stability · 9 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #35 · Data & Tools › Datasets · 8 Mar 2026 · 0 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Reused chromatograms across lots: how to spot it Replied, post #25 · Analytics › COA interpretation · 8 Mar 2026 · 3 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #71 · Evidence › Study critique · 20 Feb 2026 · 30 likes This follows post #68 rather than contradicting it. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #44 · Practice › Side effects · 9 Feb 2026 · 0 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
[2026 update] What a purity-only report leaves out Replied, post #16 · Sourcing › Independent verification · 4 Feb 2026 · 3 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Coming back to: Training through a dose escalation week Replied, post #21 · Nutrition & Training › Resistance training · 3 Feb 2026 · 0 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #16 · Evidence › Trials · 27 Jan 2026 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #11 · Sourcing › Vendor reports · 26 Dec 2025 · 7 likes I read post #9 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
Long-time reader, first-time poster Replied, post #17 · Lounge › Introductions · 15 Nov 2025 · 32 likes Coming back to post #15, because the follow-up matters more than the original answer. No spam: introductions are not a place to advertise commercial products or…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Started this topic · Access › Pricing · 14 Oct 2025 · 13 likes Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #63 · Lounge › Off topic · 28 Sep 2025 · 6 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Sleep quality changes during weight loss — what changed since Replied, post #5 · Wellbeing › Sleep · 20 Sep 2025 · 0 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #71 · Practice › Administration · 20 Sep 2025 · 27 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #16 · Evidence › Study critique · 12 Sep 2025 · 0 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #105 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #50 · Practice › Storage & stability · 8 Sep 2025 · 4 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #13 · Compounds › Tirzepatide · 5 Sep 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Replied, post #3 · Clinical › Special populations · 22 Aug 2025 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #110 · Practice › Reconstitution · 21 Aug 2025 · 19 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Can a home kit substitute for a laboratory report? A careful no Started this topic · Analytics › Home & field testing · 21 Aug 2025 · 4 likes Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to understand what this number…
-
A ten-fold dose error caught before injection — one year on Replied, post #64 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes I read post #62 twice before replying, because I had assumed the opposite. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #30 · Compounds › Retatrutide · 31 Jul 2025 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #5 · Documentation › Doc review · 19 Jul 2025 · 2 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
A field-by-field walk through a certificate of analysis Replied, post #10 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #43 · Access › Insurance & coverage · 13 Jul 2025 · 15 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Asking about a compound your prescriber has not heard of Replied, post #79 · Clinical › Prescriber conversations · 29 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Repeatability versus intermediate precision Replied, post #60 · Analytics › Method validation · 25 Jun 2025 · 24 likes I read post #58 twice before replying, because I had assumed the opposite. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat,…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #17 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 3 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Coming back to: Getting a referral rather than a refusal Replied, post #63 · Clinical › Prescriber conversations · 13 Jun 2025 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 4 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #53 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 0 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #22 · Evidence › Trials · 7 May 2025 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #24 · Compounds › Retatrutide · 12 Mar 2025 · 30 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #28 · Compounds › Other compounds · 5 Mar 2025 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #25 · Clinical › Comorbidities · 3 Mar 2025 · 16 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Attributing a new peak: degradation product or excipient? Replied, post #3 · Analytics › Impurities & related substances · 4 Feb 2025 · 7 likes post #2 is right about the mechanism and I think understates the practical bit. Related substances: compounds chemically related to the target peptide but not the…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #28 · Sourcing › Vendor reports · 31 Jan 2025 · 0 likes On post #24 — agreed on the reasoning, with one qualification. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #5 · Access › International · 19 Jan 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] New subcategory: rationale and scope Replied, post #129 · Meta › Announcements · 7 Jan 2025 · 23 likes post #128 is right about the mechanism and I think understates the practical bit. When announcements are made: major policy changes, technical changes affecting site…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #52 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #82 · Analytics › Method validation · 16 Dec 2024 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #48 · Nutrition & Training › Protein & intake · 10 Dec 2024 · 19 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #8 · Sourcing › Vendor reports · 24 Nov 2024 · 4 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #79 · Analytics › Method validation · 23 Nov 2024 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #32 · Wellbeing › Mental health · 15 Oct 2024 · 16 likes Worth separating two things that post #28 runs together. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function,…
-
When a preprint is the best available evidence and we say so — a second dataset Started this topic · Evidence › Preprints · 27 Aug 2024 · 13 likes When a preprint is the best available evidence and we say so — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #149 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Picking up post #146: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #15 · Sourcing › Independent verification · 24 Aug 2024 · 2 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #16 · Compounds › Semaglutide · 21 Aug 2024 · 23 likes I read post #14 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Follow-up: Reporting a discrepancy without making an allegation Started this topic · Sourcing › Vendor reports · 9 Aug 2024 · 44 likes Reporting a discrepancy without making an allegation Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #2 · Practice › Interactions · 4 Jul 2024 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…